The Utility of Long-Read Sequencing in Diagnosing Genetic Autosomal Recessive Parkinson's Disease: a genetic screening study

Kensuke Daida Dr,Hiroyo Yoshino Dr,Laksh Malik Dr,Breeana Baker Dr,Mayu Ishiguro Dr,Rylee Genner Dr,Kimberly Paquette Dr,Yuanzhe Li Dr,Kenya Nishioka Dr,Satoshi Masuzugawa Dr,Makito Hirano Dr,Kenta Takahashi Dr,Mikhail Kolmogolv Dr,Kimberly J Billingsley Dr,Manabu Funayama Dr,Cornelis Blauwendraat Dr,Nobutaka Hattori Dr

DOI: https://doi.org/10.1101/2024.06.14.24308784

2024-06-15

Abstract:Background Mutations within the genes PRKN and PINK1 are the leading cause of early onset autosomal recessive Parkinson's disease (PD). However, the genetic cause of most early-onset PD (EOPD) cases still remains unresolved. Long-read sequencing has successfully identified many pathogenic structural variants that cause disease, but this technology has not been widely applied to PD. We recently identified the genetic cause of EOPD in a pair of monozygotic twins by uncovering a complex structural variant that spans over 7 Mb, utilizing Oxford Nanopore Technologies (ONT) long-read sequencing. In this study, we aimed to expand on this and assess whether a second variant could be detected with ONT long-read sequencing in other unresolved EOPD cases reported to carry one heterozygous variant in PRKN or PINK1. Methods ONT long-read sequencing was performed on patients with one reported PRKN/PINK1 pathogenic variant. EOPD patients with an age at onset younger than 50 were included in this study. As a positive control, we also included EOPD patients who had already been identified to carry two known PRKN pathogenic variants. Initial genetic testing was performed using either short-read targeted panel sequencing for single nucleotide variants and multiplex ligation-dependent probe amplification (MLPA) for copy number variants. Results 48 patients were included in this study (PRKN 'one-variant' n = 24, PINK1 'one-variant' n = 12, PRKN 'two-variants' n = 12). Using ONT long-read sequencing, we detected a second pathogenic variant in six PRKN 'one-variant' patients (26%, 6/23) but none in the PINK1 'one-variant' patients (0%, 0/12). Long-read sequencing identified one case with a complex inversion, two instances of structural variant overlap, and three cases of duplication. In addition, in the positive control PRKN 'two-variants' group, we were able to identify both pathogenic variants in PRKN in all the patients (100%, 12/12). Conclusions This data highlights that ONT long-read sequencing is a powerful tool to identify a pathogenic structural variant at the PRKN locus that is often missed by conventional methods. Therefore, for cases where conventional methods fail to detect a second variant for EOPD, long-read sequencing should be considered as an alternative and complementary approach.

Neurology